Abstract
Objective: As the prevalence of chronic diseases among the elderly increases annually, chronic renal insufficiency caused by hypertension has become a critical global health issue. This study aims to compare the decline in estimated glomerular filtration rate (eGFR) between hypertensive and non-hypertensive elderly populations in Yunnan, China, under non-intervention conditions to explore the impact of blood pressure on renal health.
Methods: A retrospective analysis was conducted on 1,856 elderly individuals (aged 65+) with a six-year follow-up period (2017–2023). eGFR was calculated using serum creatinine levels, and participants were categorized by blood pressure levels and age groups.
Results: The incidence of hypertension in this cohort was significantly higher than the national average. Hypertensive patients exhibited a significantly lower eGFR and a faster rate of decline compared to non-hypertensive peers. Maintaining blood pressure below 120/80 mmHg was associated with the lowest eGFR decline ratio.
Conclusion: Lowering blood pressure effectively slows the decline of eGFR. Public health efforts should prioritize reducing hypertension prevalence to preserve renal function in aging populations.
Introduction
As global populations age, the intersection of hypertension and chronic kidney disease (CKD) has emerged as a major public health challenge. While the link between high blood pressure and renal damage is well-established, long-term comparative data specifically focusing on the elderly in high-prevalence regions like Yunnan, China, remains scarce. This paper addresses the "natural" progression of renal decline—measured via the estimated glomerular filtration rate (eGFR)—in a real-world, non-intervention setting. By quantifying the accelerated deterioration of kidney function in hypertensive seniors, the study evaluates whether standard clinical blood pressure targets are sufficient to protect renal health.
Methods and Materials
The researchers conducted a retrospective cross-sectional analysis of 1,856 elderly individuals (aged 65–86) residing in the Guandu District of Kunming. Data were extracted from health screenings conducted in 2017 and 2023.
Participants were identified through phone number matching across both screening years. From an initial pool of 2,000, the final cohort of 1,856 was established after excluding individuals with End-Stage Renal Disease (ESRD), those over 80 years old at the start of the study, or those with incomplete medical records. The demographic breakdown was 36.53% male and 63.47% female. Blood pressure was measured using mercury monitors, and renal function was assessed via serum creatinine (Scr) using the standard formula: $eGFR = 186 \times \text{Scr}^{-1.154} \times \text{Age}^{-0.203} \times [0.742 \text{ if female}]$.
Results
Regional Hypertension Trends
The study revealed a localized public health crisis in the Yunnan region. The prevalence of hypertension in this elderly cohort was 46.23% in 2017, rising to 49.30% by 2023—figures significantly higher than the Chinese national average of 27.5%.
Accelerated Renal Decline
Over the six-year follow-up, hypertensive patients experienced a markedly faster decline in kidney function. Specifically, hypertensive individuals saw an eGFR decline of 13.28% (a decrease of 9.59 ml/min), whereas non-hypertensive individuals declined by only 8.32% (7.2 ml/min). This difference was statistically significant ($P < 0.05$), underscoring the role of high blood pressure as a primary driver of renal aging.
Discussion and Key Insights
The 120/80 mmHg Threshold
A critical finding of this research is the inverse relationship between blood pressure levels and filtration rates. The highest eGFR values were consistently found in patients whose blood pressure remained below 120/80 mmHg. This suggests that the common clinical target of <140/90 mmHg may be insufficient for preventing hypertensive nephropathy in the elderly. As blood pressure increases, elevated systolic pressure causes physical damage to the glomeruli through endothelial stress and lipid deposition, eventually leading to glomerulosclerosis.
Age-Specific Vulnerability
The rate of eGFR decline was found to be steepest in the 70–74 age bracket. The authors attribute this trend to lower blood pressure control compliance within this specific demographic. Furthermore, the study noted higher participation rates among women, likely due to longer average lifespans and a higher proactive interest in community health screenings.
Limitations
As a retrospective study, the findings may be subject to selection bias. Additionally, the non-intervention context means that specific antihypertensive medication regimens were not controlled. Finally, environmental or dietary factors unique to the Kunming region may limit the generalizability of these results to broader global populations.
Conclusion
Hypertension significantly accelerates the decline of eGFR in the elderly population of Yunnan. The data strongly suggests that maintaining blood pressure below 120/80 mmHg is the most effective strategy for slowing renal deterioration. Future public health initiatives should focus on aggressive blood pressure management and the mitigation of secondary risk factors, such as oxidative stress and insulin resistance, to preserve kidney function in the aging population.
Summary updated